Progyny, Inc. (PGNY)
Progyny, Inc. operates in the Medical - Healthcare Plans industry of the Healthcare sector, headquartered in New York City, NY, US. The stock last traded at $26.29, up 2.46% on the session, giving a market capitalisation of $2.06B. On trailing twelve-month figures it carries a trailing P/E of 27.10, a net margin of 6.0%. Its beta of 1.02 implies it has historically moved more than the broad market.
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
Progyny, Inc. is most often compared with the following Healthcare names: